Expanded Access Policy

Clinical trials, and the subsequent approval of a therapy, provide the best way to provide long-term access to new therapies to as many patients as possible. Outside of where a patient has participated in one of its clinical trials, Ikena Oncology (“Ikena”) does not currently accept or grant requests for expanded access to any of its investigational drugs. Patients interested in an investigational drug which has not yet been approved are encouraged to speak with their doctor and potentially participate in one of Ikena’s clinical trials. Information on Ikena’s clinical trials can be found at www.clinicaltrials.gov.

Scroll to Top